Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Sträussler-Scheinker disease amyloid protein

Luana Fioriti, Nadia Angeretti, Laura Colombo, Ada De Luigi, Alessio Colombo, Claudia Manzoni, Michela Morbin, Fabrizio Tagliavini, Mario Salmona, Roberto Chiesa, Gianluigi Forloni

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Amyloid fibrils in Gerstmann-Sträussler-Scheinker (GSS) disease are composed of a fragment of the prion protein (PrP), the N and C termini of which correspond to ragged residues 81-90 and 144-153. A synthetic peptide spanning the sequence 82-146 (PrP 82-146) polymerizes into protease-resistant fibrils with the tinctorial properties of amyloid. We investigated the biological activity of PrP 82-146 and of two nonamyloidogenic variants of PrP 82-146 with scrambled amino acid sequence 106-126 or 127-146. Cortical neurons prepared from rat and mouse embryos were chronically exposed to the PrP 82-146 peptides (10-50 μM). PrP 82-146 and the partially scrambled peptides induced neuronal death with a similar dose-response pattern, indicating that neurotoxicity was independent of amyloid fibril formation. Neurotoxicity was significantly reduced by coadministration of an anti-oligomer antibody, suggesting that PrP 82-146 oligomers are primarily responsible for triggering cell death. Neurons from PrP knock-out (Prnp0/0) mice were significantly less sensitive to PrP 82-146 toxicity than neurons expressing PrP. The gliotrophic effect of PrP 82-146 was determined by [methyl-3H]-thymidine incorporation in cultured astrocytes. Treatment with PrP 82-146 stimulated [methyl-3H]- thymidine uptake 3.5-fold. This activity was significantly less when the 106-126 or 127-146 regions were disrupted, indicating that PrP 82-146 amyloid activates the gliotrophic response. Prnp0/0 astrocytes were insensitive to the proliferative stimulus of PrP 82-146. These results underline the role of cerebral accumulation of abnormally folded PrP fragments and indicate that cellular PrP governs the pathogenic process.

Original languageEnglish
Pages (from-to)1576-1583
Number of pages8
JournalJournal of Neuroscience
Volume27
Issue number7
DOIs
Publication statusPublished - Feb 14 2007

Fingerprint

Amyloidogenic Proteins
Peptides
Amyloid
Neurons
Astrocytes
Thymidine
prion protein (82-146)
Protein C
Anti-Idiotypic Antibodies
Amino Acid Sequence
Peptide Hydrolases
Cell Death
Embryonic Structures

Keywords

  • Amyloid
  • Apoptosis
  • Astrocytes
  • Neuron
  • Neurotoxicity
  • Prion

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Sträussler-Scheinker disease amyloid protein. / Fioriti, Luana; Angeretti, Nadia; Colombo, Laura; De Luigi, Ada; Colombo, Alessio; Manzoni, Claudia; Morbin, Michela; Tagliavini, Fabrizio; Salmona, Mario; Chiesa, Roberto; Forloni, Gianluigi.

In: Journal of Neuroscience, Vol. 27, No. 7, 14.02.2007, p. 1576-1583.

Research output: Contribution to journalArticle

@article{e7f3932baab7407483a5e76958c0202c,
title = "Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Str{\"a}ussler-Scheinker disease amyloid protein",
abstract = "Amyloid fibrils in Gerstmann-Str{\"a}ussler-Scheinker (GSS) disease are composed of a fragment of the prion protein (PrP), the N and C termini of which correspond to ragged residues 81-90 and 144-153. A synthetic peptide spanning the sequence 82-146 (PrP 82-146) polymerizes into protease-resistant fibrils with the tinctorial properties of amyloid. We investigated the biological activity of PrP 82-146 and of two nonamyloidogenic variants of PrP 82-146 with scrambled amino acid sequence 106-126 or 127-146. Cortical neurons prepared from rat and mouse embryos were chronically exposed to the PrP 82-146 peptides (10-50 μM). PrP 82-146 and the partially scrambled peptides induced neuronal death with a similar dose-response pattern, indicating that neurotoxicity was independent of amyloid fibril formation. Neurotoxicity was significantly reduced by coadministration of an anti-oligomer antibody, suggesting that PrP 82-146 oligomers are primarily responsible for triggering cell death. Neurons from PrP knock-out (Prnp0/0) mice were significantly less sensitive to PrP 82-146 toxicity than neurons expressing PrP. The gliotrophic effect of PrP 82-146 was determined by [methyl-3H]-thymidine incorporation in cultured astrocytes. Treatment with PrP 82-146 stimulated [methyl-3H]- thymidine uptake 3.5-fold. This activity was significantly less when the 106-126 or 127-146 regions were disrupted, indicating that PrP 82-146 amyloid activates the gliotrophic response. Prnp0/0 astrocytes were insensitive to the proliferative stimulus of PrP 82-146. These results underline the role of cerebral accumulation of abnormally folded PrP fragments and indicate that cellular PrP governs the pathogenic process.",
keywords = "Amyloid, Apoptosis, Astrocytes, Neuron, Neurotoxicity, Prion",
author = "Luana Fioriti and Nadia Angeretti and Laura Colombo and {De Luigi}, Ada and Alessio Colombo and Claudia Manzoni and Michela Morbin and Fabrizio Tagliavini and Mario Salmona and Roberto Chiesa and Gianluigi Forloni",
year = "2007",
month = "2",
day = "14",
doi = "10.1523/JNEUROSCI.5145-06.2007",
language = "English",
volume = "27",
pages = "1576--1583",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "7",

}

TY - JOUR

T1 - Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Sträussler-Scheinker disease amyloid protein

AU - Fioriti, Luana

AU - Angeretti, Nadia

AU - Colombo, Laura

AU - De Luigi, Ada

AU - Colombo, Alessio

AU - Manzoni, Claudia

AU - Morbin, Michela

AU - Tagliavini, Fabrizio

AU - Salmona, Mario

AU - Chiesa, Roberto

AU - Forloni, Gianluigi

PY - 2007/2/14

Y1 - 2007/2/14

N2 - Amyloid fibrils in Gerstmann-Sträussler-Scheinker (GSS) disease are composed of a fragment of the prion protein (PrP), the N and C termini of which correspond to ragged residues 81-90 and 144-153. A synthetic peptide spanning the sequence 82-146 (PrP 82-146) polymerizes into protease-resistant fibrils with the tinctorial properties of amyloid. We investigated the biological activity of PrP 82-146 and of two nonamyloidogenic variants of PrP 82-146 with scrambled amino acid sequence 106-126 or 127-146. Cortical neurons prepared from rat and mouse embryos were chronically exposed to the PrP 82-146 peptides (10-50 μM). PrP 82-146 and the partially scrambled peptides induced neuronal death with a similar dose-response pattern, indicating that neurotoxicity was independent of amyloid fibril formation. Neurotoxicity was significantly reduced by coadministration of an anti-oligomer antibody, suggesting that PrP 82-146 oligomers are primarily responsible for triggering cell death. Neurons from PrP knock-out (Prnp0/0) mice were significantly less sensitive to PrP 82-146 toxicity than neurons expressing PrP. The gliotrophic effect of PrP 82-146 was determined by [methyl-3H]-thymidine incorporation in cultured astrocytes. Treatment with PrP 82-146 stimulated [methyl-3H]- thymidine uptake 3.5-fold. This activity was significantly less when the 106-126 or 127-146 regions were disrupted, indicating that PrP 82-146 amyloid activates the gliotrophic response. Prnp0/0 astrocytes were insensitive to the proliferative stimulus of PrP 82-146. These results underline the role of cerebral accumulation of abnormally folded PrP fragments and indicate that cellular PrP governs the pathogenic process.

AB - Amyloid fibrils in Gerstmann-Sträussler-Scheinker (GSS) disease are composed of a fragment of the prion protein (PrP), the N and C termini of which correspond to ragged residues 81-90 and 144-153. A synthetic peptide spanning the sequence 82-146 (PrP 82-146) polymerizes into protease-resistant fibrils with the tinctorial properties of amyloid. We investigated the biological activity of PrP 82-146 and of two nonamyloidogenic variants of PrP 82-146 with scrambled amino acid sequence 106-126 or 127-146. Cortical neurons prepared from rat and mouse embryos were chronically exposed to the PrP 82-146 peptides (10-50 μM). PrP 82-146 and the partially scrambled peptides induced neuronal death with a similar dose-response pattern, indicating that neurotoxicity was independent of amyloid fibril formation. Neurotoxicity was significantly reduced by coadministration of an anti-oligomer antibody, suggesting that PrP 82-146 oligomers are primarily responsible for triggering cell death. Neurons from PrP knock-out (Prnp0/0) mice were significantly less sensitive to PrP 82-146 toxicity than neurons expressing PrP. The gliotrophic effect of PrP 82-146 was determined by [methyl-3H]-thymidine incorporation in cultured astrocytes. Treatment with PrP 82-146 stimulated [methyl-3H]- thymidine uptake 3.5-fold. This activity was significantly less when the 106-126 or 127-146 regions were disrupted, indicating that PrP 82-146 amyloid activates the gliotrophic response. Prnp0/0 astrocytes were insensitive to the proliferative stimulus of PrP 82-146. These results underline the role of cerebral accumulation of abnormally folded PrP fragments and indicate that cellular PrP governs the pathogenic process.

KW - Amyloid

KW - Apoptosis

KW - Astrocytes

KW - Neuron

KW - Neurotoxicity

KW - Prion

UR - http://www.scopus.com/inward/record.url?scp=33847166240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847166240&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.5145-06.2007

DO - 10.1523/JNEUROSCI.5145-06.2007

M3 - Article

C2 - 17301166

AN - SCOPUS:33847166240

VL - 27

SP - 1576

EP - 1583

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 7

ER -